Coming October 29: SITC releases its late-breaking abstract titles. We’ll add their presenting authors’ institutions to this guide once they’re out.

Isosceles Pharmaceuticals at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Isosceles Pharmaceuticals brings 2 presentations to SITC 2026 in Phoenix. Its program centres on IPI201, a small-molecule compound studied in colorectal cancer. The work tests how it affects natural killer cell killing of tumor cells and how it performs alongside anti-PD-1 therapy in a mouse model.

OrganizationSITC 2026 Attendance
isoscelespharma.com
Biotech
Develops small-molecule immunotherapy adjuvants intended to enhance checkpoint inhibitor and natural killer cell therapies.
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Isosceles Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction